Expeditors International heads into its May 5 Q1 earnings report with options traders the most defensively positioned they have been in months, even as the stock quietly outperforms a struggling peer group.
The clearest signal this week is in the options market. The put/call ratio has jumped to 0.31, more than 2.7 standard deviations above its 20-day mean of 0.23 — a reading that stands well outside its normal range and marks the most elevated defensive tilt in recent months. That's a meaningful shift for a name where the PCR has spent most of the past six weeks below 0.22. The move suggests traders are buying protection into the print rather than expressing directional conviction either way.
Short interest tells a less charged story. At 3.3% of free float, the short position is modest by any measure — and it just fell sharply, dropping more than 12% over the past week to around 4.4 million shares. That reverses a mid-April build that briefly pushed borrowed shares close to 5.1 million. Borrow conditions are easy: the cost to borrow is running at roughly 0.43% annualised, down nearly 17% on the week, and availability remains loose. The ORTEX short score has drifted lower all week, now at 36.0 from 38.0 a week ago, reflecting the easing pressure. There is no squeeze dynamic here — the lending market is relaxed and shorts have been covering, not pressing.
The Street is similarly non-committal. Every analyst in the data carries a Hold or bearish rating — eight Holds and at least two Underweight ratings, with no Buy on the board except UBS, which upgraded to Buy in November 2025 with a $166 target. The most recent analyst actions, from late February, were mixed: Freedom Broker nudged its target up to $144 while Truist and Susquehanna both trimmed theirs to $140–$142 after the Q4 print. JP Morgan holds an Underweight with a $132 target, and Morgan Stanley's Underweight carries a $95 target — both well below the current price of $148.79. The valuation picture is undemanding on earnings yield but not cheap on price-to-book at 7.9x, and the EV/EBITDA multiple has edged lower over the past month. Factor scores offer little conviction: EPS momentum ranks near the median, forward EPS growth scores only 37th percentile, and the dividend score — at 97th percentile — is the standout, though the dividend history in the data is stale and should be treated with caution.
Against its peer group, Expeditors is holding up well. The stock gained 0.24% on the week, while closest peer CHRW managed a modest 2.2% gain. The rest of the group fared worse: FWRD fell 5.5%, DSV dropped 5.8%, and HUBG slid 2.5%. That relative resilience — in a week when freight names broadly sold off — is notable context heading into a report.
Earnings history adds texture without providing comfort. The last Q4 print in February triggered a 5.2% single-day drop, and a weak five-day follow-through. The November 2025 print was the opposite: the stock surged 12.6% on the day and extended to nearly 14% over five sessions. The alternating reaction pattern means the range of outcomes is wide, and the options-market hedging this week reflects exactly that uncertainty.
The May 5 print is the next thing to watch — specifically whether management's commentary on trade volumes and tariff-related disruption matches or diverges from the cautious tone the options market is pricing in right now.
See the live data behind this article on ORTEX.
Open EXPD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
